2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Symposium

2013 Symposium Photos

2012 Featured Talks

2012 Symposium Photos

2011 Featured Talks

2011 Symposium Photos

Past Symposia in the Press

2013 Featured Talks » From bench to FDA approval at the Moores Cancer Center

From bench to FDA approval at the Moores Cancer Center

Anne Wallace, MD, is the Chief of the Division of Plastic, concurrently with her role as Team Leader of the Moores Cancer Center’s breast program. She has extensive experience in all aspects of breast health specifically breast cancer and breast reconstruction and melanomas. She is experienced in all forms of cosmetic breast, body contouring surgery and other reconstructive procedures. Dr. Wallace completed a fellowship in microvascular cancer reconstruction at MD Anderson Cancer Center in Houston, TX, her residency in plastic surgery at UC San Diego, and both her residency and internship in general surgery at Washington Hospital Center. She earned her medical degree at Creighton University in Omaha, NE, and her bachelor’s degree with honors at Georgetown University.

Dr. Wallace’s focus of research has been in the development of molecular targeted imaging agents used for the detection of breast cancer and melanoma. However, she has led the breast team in building a large scale clinical trials program, including novel neoadjuvant therapies and risk management. Dr. Wallace has served as chairman of the California Breast Cancer Research Council and vice-president of Cancer Control for the Golden Triangle Division of the American Cancer Society. She was honored as a Komen Foundation Breast Cancer Clinician of the Year, Clinical Teacher of the Year in our Division of Plastic Surgery, and a TWIN awardee for women in business.